Literature DB >> 23383401

Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model.

Meghan N Le1, Wonhee Kim, Sangmook Lee, Ann C McKee, Garth F Hall.   

Abstract

While the interneuronal propagation of neurofibrillary lesions in Alzheimer's disease and other tauopathies now appears to involve the spreading of tau-associated toxicity, little is known about its mechanism. We characterized the movement of human tau through the brain of a non-transgenic lower vertebrate tauopathy model in which full-length wild type and mutant human tau isoforms were expressed in identified neurons, thus permitting the identification and localization of EC tau sources. We describe two distinct patterns of tau spreading that correspond to tau species that lack (MTBR-) and contain (MTBR+) the tau microtubule-binding region. These patterns illustrate the production, migration and uptake of EC tau and resemble some of the extracellular tau deposits typically seen in human brain after repeated traumatic injury in cases of chronic traumatic encephalopathy (CTE). We propose that misprocessed human tau can spread between CNS neurons via a variety of non-synaptic mechanisms as well as synaptically mediated mechanisms.

Entities:  

Keywords:  CSF-tau; chronic traumatic encephalopathy; interneuronal lesion spread; neuron death; tau secretion

Year:  2012        PMID: 23383401      PMCID: PMC3560471     

Source DB:  PubMed          Journal:  Am J Neurodegener Dis        ISSN: 2165-591X


  74 in total

1.  Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model.

Authors:  Lee E Goldstein; Andrew M Fisher; Chad A Tagge; Xiao-Lei Zhang; Libor Velisek; John A Sullivan; Chirag Upreti; Jonathan M Kracht; Maria Ericsson; Mark W Wojnarowicz; Cezar J Goletiani; Giorgi M Maglakelidze; Noel Casey; Juliet A Moncaster; Olga Minaeva; Robert D Moir; Christopher J Nowinski; Robert A Stern; Robert C Cantu; James Geiling; Jan K Blusztajn; Benjamin L Wolozin; Tsuneya Ikezu; Thor D Stein; Andrew E Budson; Neil W Kowall; David Chargin; Andre Sharon; Sudad Saman; Garth F Hall; William C Moss; Robin O Cleveland; Rudolph E Tanzi; Patric K Stanton; Ann C McKee
Journal:  Sci Transl Med       Date:  2012-05-16       Impact factor: 17.956

Review 2.  Tau protein pathology in neurodegenerative diseases.

Authors:  M G Spillantini; M Goedert
Journal:  Trends Neurosci       Date:  1998-10       Impact factor: 13.837

3.  Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy.

Authors:  G F Hall; V M Lee; G Lee; J Yao
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

4.  Tau polymerization: role of the amino terminus.

Authors:  T Chris Gamblin; Robert W Berry; Lester I Binder
Journal:  Biochemistry       Date:  2003-02-25       Impact factor: 3.162

5.  Neurons may live for decades with neurofibrillary tangles.

Authors:  R Morsch; W Simon; P D Coleman
Journal:  J Neuropathol Exp Neurol       Date:  1999-02       Impact factor: 3.685

6.  The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains.

Authors:  J Biernat; E M Mandelkow
Journal:  Mol Biol Cell       Date:  1999-03       Impact factor: 4.138

7.  Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

Authors:  Katharina Buerger; Raymond Zinkowski; Stefan J Teipel; Tero Tapiola; Hiroyuki Arai; Kaj Blennow; Niels Andreasen; Klaus Hofmann-Kiefer; John DeBernardis; Daniel Kerkman; Cheryl McCulloch; Russell Kohnken; Frank Padberg; Tuula Pirttilä; Marc B Schapiro; Stanley I Rapoport; Hans-Jürgen Möller; Peter Davies; Harald Hampel
Journal:  Arch Neurol       Date:  2002-08

8.  Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules.

Authors:  Daniela Fischer; Marco D Mukrasch; Jacek Biernat; Stefan Bibow; Martin Blackledge; Christian Griesinger; Eckhard Mandelkow; Markus Zweckstetter
Journal:  Biochemistry       Date:  2009-10-27       Impact factor: 3.162

9.  Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model.

Authors:  Y P Wang; J Biernat; M Pickhardt; E Mandelkow; E-M Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

10.  Trans-synaptic spread of tau pathology in vivo.

Authors:  Li Liu; Valerie Drouet; Jessica W Wu; Menno P Witter; Scott A Small; Catherine Clelland; Karen Duff
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

View more
  14 in total

1.  Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer's disease.

Authors:  Sudad Saman; Norman C Y Lee; Itoro Inoyo; Jun Jin; Zhihan Li; Thomas Doyle; Ann C McKee; Garth F Hall
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Traumatic brain injury may increase risk of young onset dementia.

Authors:  Raquel C Gardner; Kristine Yaffe
Journal:  Ann Neurol       Date:  2014-03-07       Impact factor: 10.422

Review 3.  Linking traumatic brain injury to chronic traumatic encephalopathy: identification of potential mechanisms leading to neurofibrillary tangle development.

Authors:  Brandon Peter Lucke-Wold; Ryan Coddington Turner; Aric Flint Logsdon; Julian Edwin Bailes; Jason Delwyn Huber; Charles Lee Rosen
Journal:  J Neurotrauma       Date:  2014-04-11       Impact factor: 5.269

4.  Spinal cord injury and Alzheimer's disease risk: a population-based, retrospective cohort study.

Authors:  Tian-Shin Yeh; Yu-Chun Ho; Cherng-Lan Hsu; Shin-Liang Pan
Journal:  Spinal Cord       Date:  2017-10-23       Impact factor: 2.772

5.  Rapid accumulation of endogenous tau oligomers in a rat model of traumatic brain injury: possible link between traumatic brain injury and sporadic tauopathies.

Authors:  Bridget E Hawkins; Shashirekha Krishnamurthy; Diana L Castillo-Carranza; Urmi Sengupta; Donald S Prough; George R Jackson; Douglas S DeWitt; Rakez Kayed
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

6.  When amyloids become prions.

Authors:  Raimon Sabate
Journal:  Prion       Date:  2014-05-15       Impact factor: 3.931

7.  Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies.

Authors:  Parmenion P Tsitsopoulos; Niklas Marklund
Journal:  Front Neurol       Date:  2013-06-26       Impact factor: 4.003

Review 8.  Could α-synuclein amyloid-like aggregates trigger a prionic neuronal invasion?

Authors:  Maria Antònia Busquets; Alba Espargaró; Joan Estelrich; Raimon Sabate
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

9.  Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head trauma.

Authors:  Joseph Ojo; Max Eisenbaum; Ben Shackleton; Cillian Lynch; Utsav Joshi; Nicole Saltiel; Andrew Pearson; Charis Ringland; Daniel Paris; Benoit Mouzon; Michael Mullan; Fiona Crawford; Corbin Bachmeier
Journal:  Neurobiol Dis       Date:  2020-12-28       Impact factor: 5.996

Review 10.  Extracellular Membrane Vesicles as Vehicles for Brain Cell-to-Cell Interactions in Physiological as well as Pathological Conditions.

Authors:  Gabriella Schiera; Carlo Maria Di Liegro; Italia Di Liegro
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.